Analysis of longitudinal data in an Alzheimer's disease clinical trial
- 22 May 2000
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 19 (11-12), 1433-1440
- https://doi.org/10.1002/(sici)1097-0258(20000615/30)19:11/12<1433::aid-sim435>3.0.co;2-f
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's diseaseNeurology, 1998
- A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for DementiaJama-Journal Of The American Medical Association, 1997
- Treatment of Alzheimer's Disease — Searching for a Breakthrough, Settling for LessNew England Journal of Medicine, 1997
- A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's DiseaseNew England Journal of Medicine, 1997
- Modeling the Drop-Out Mechanism in Repeated-Measures StudiesJournal of the American Statistical Association, 1995
- Stratification of summary statistic tests according to missing data patternsStatistics in Medicine, 1994
- A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's DiseaseJama-Journal Of The American Medical Association, 1994
- Analysis of serial measurements in medical research.BMJ, 1990
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975